Events2Join

Time Course for Benefit and Risk of Clopidogrel and Aspirin After ...


Time Course for Benefit and Risk of Clopidogrel and Aspirin After ...

The benefit of clopidogrel-aspirin occurs predominantly within the first 21 days, and outweighs the low, but ongoing risk of major hemorrhage.

Time Course for Benefit and Risk of Clopidogrel and Aspirin After ...

After minor ischemic stroke or high-risk transient ischemic attack, 21 days of treatment with clopidogrel combined with aspirin may maximize benefit and reduce ...

Duration of Benefit and Risk of Dual Antiplatelet Therapy up to 72 ...

Background and objectives: Clopidogrel-aspirin initiated within 72 hours of symptom onset is effective in patients with mild ischemic stroke or ...

Time Course for Benefit and Risk With Ticagrelor and Aspirin in ...

Dual antiplatelet therapy (DAPT) with P2Y12 inhibitors added to aspirin started within 24 hours after symptoms onset has been shown to be an ...

Time Course for Benefit and Risk of Clopidogrel and Aspirin After ...

BACKGROUND:In patients with acute minor ischemic stroke or high-risk transient ischemic attack enrolled in the POINT trial (Platelet-Oriented Inhibition in ...

Time Course for Benefit and Risk of Clopidogrel and Aspirin After ...

Models showed benefits of clopidogrel-aspirin for treatment delayed as long as 3 days after symptom onset. CONCLUSIONS: The benefit of ...

Clopidogrel and Aspirin Initiated Between 24 to 72 Hours for Mild ...

Meaning The results of this study suggest that patients with mild ischemic stroke or TIA can benefit from dual antiplatelet therapy with ...

Time Course for Benefit and Risk of Clopidogrel and Aspirin After ...

Background: In patients with acute minor ischemic stroke or high-risk transient ischemic attack enrolled in the POINT trial, the combination ...

Risks and benefits of clopidogrel–aspirin in minor stroke or TIA

This time course analysis showed that clopidogrel–aspirin treatment may have a benefit of reducing ischemic stroke risk outweighing the potential risk of ...

Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA

Combination antiplatelet therapy with clopidogrel and aspirin may reduce the rate of recurrent stroke during the first 3 months after a minor ischemic stroke ...

Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute ...

A previous time-course analysis of the Platelet Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) trial demonstrated that the benefit of ...

Duration of Benefit for Dual Antiplatelet Therapy After Mild Ischemic ...

The benefits of DAPT over aspirin alone were front-loaded, with a 1.42% absolute risk reduction (ARR) for major ischemic events in the first ...

Clopidogrel-Aspirin in Minor Stroke/TIA of Maximum Benefit in First ...

For patients presenting with acute minor stroke or high-risk TIA, the risk-benefit balance when using clopidogrel plus aspirin appears to be ...

Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke

The effect of clopidogrel plus aspirin as compared with aspirin alone administered within 72 hours after the onset of acute cerebral ischemia ...

Optimal duration of dual antiplatelet therapy for minor stroke within ...

Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke. Circulation ...

Dual Antiplatelet Therapy for High-Risk TIA and Minor Stroke - AAFP

After 10 to 21 days of daily low-dose aspirin and clopidogrel, 75 mg, the patient should be switched to a single antiplatelet drug. From the AFP ...

Duration of Dual Antiplatelet Therapy Following Minor Stroke or TIA

Time-course analysis of CHANCE-2 trial data suggests that patients with impaired clopidogrel metabolism benefit most from DAPT in the first ...

Critique on the Use of Early Short-Term Dual Antiplatelet Therapy ...

Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke. Circulation . 2019 ...

Benefits and Risks of Clopidogrel vs. Aspirin Monotherapy after ...

Five studies meeting eligibility criteria were included in the analysis. A total of 29,357 adult patients who had recent ischemic stroke ...

Long-term antithrombotic therapy for the secondary prevention of ...

- Early benefit · - Dose of aspirin · - Aspirin resistance · - Adverse effects ... - Cilostazol plus aspirin or clopidogrel · Combination ...